TY - JOUR
T1 - Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea
AU - Jackson, J. Mark
AU - Lorenz, Douglas J.
AU - Kircik, Leon H.
PY - 2013/3
Y1 - 2013/3
N2 - Rosacea is one of the most commonly occurring dermatoses treated by dermatologists. There are multiple therapeutic options available for the treatment of papulopustular rosacea. Rosacea is an inflammatory condition, classically presenting with flushing and/ or blushing along with erythema, edema, telangiectasia, papules, pustules, and nodules of the face. Minocycline, a member of the tetracycline family, has demonstrated benefit in the treatment of inflammatory lesions in patients with rosacea. This manuscript highlights the use of a new sustained-release low-dose minocycline 45 mg tablet, with or without azelaic acid, for the treatment of papulopustular rosacea.
AB - Rosacea is one of the most commonly occurring dermatoses treated by dermatologists. There are multiple therapeutic options available for the treatment of papulopustular rosacea. Rosacea is an inflammatory condition, classically presenting with flushing and/ or blushing along with erythema, edema, telangiectasia, papules, pustules, and nodules of the face. Minocycline, a member of the tetracycline family, has demonstrated benefit in the treatment of inflammatory lesions in patients with rosacea. This manuscript highlights the use of a new sustained-release low-dose minocycline 45 mg tablet, with or without azelaic acid, for the treatment of papulopustular rosacea.
UR - http://www.scopus.com/inward/record.url?scp=84874613439&partnerID=8YFLogxK
M3 - Article
C2 - 23545911
AN - SCOPUS:84874613439
SN - 1545-9616
VL - 12
SP - 292
EP - 298
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 3
ER -